About Joshua Ziel
Joshua Ziel is an executive officer at Bryn Pharma.
Form D filings also name Joshua Ziel as a chief operating officer at Aerami Therapeutics Holdings.
Joshua Ziel first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Joshua Ziel in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joshua Ziel works with at each company, as listed on that company's latest Form D.
Bryn Pharma, Inc. · Form D, Aug 14, 2025
AW
Anne Whitaker
Director
MK
Michael Kaseta
Director
JH
Jeff Hartness
Director
SH
Steven Hartman
Director
ML
Michelle Lobel
Director
SK
MR
Marc Rapaport
Director
LL
Lisa Licht
Director
SL
Sandra Loreaux
Director
JB
James Borneman
Executive officer
KD
Kate Soper Diaz
Director
Aerami Therapeutics Holdings, Inc. · Form D, Nov 22, 2023
GB
Gary Burgess
Chief Medical Officer
AW
Anne Whitaker
Chief Executive Officer, Chairwoman of the Board
AS
Adam Stern
Director
JP
John Patton
Director
ST
Steven Thornton
Director
WW
William Welch
Director
DH
Darlene Deptula-Hicks
Chief Financial Officer and Director